Home > Publications database > Interactions of Mycoplasma genitalium (Mg) and human papillomavirus (HPV) infections among couples. > print

001     307449
005     20251231120304.0
024 7 _ |a 10.1186/s12879-025-12334-y
|2 doi
024 7 _ |a pmid:41430645
|2 pmid
037 _ _ |a DKFZ-2025-03048
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Koskela, Nea
|0 0009-0002-0337-7420
|b 0
245 _ _ |a Interactions of Mycoplasma genitalium (Mg) and human papillomavirus (HPV) infections among couples.
260 _ _ |a London
|c 2025
|b BioMed Central
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1767096163_1386405
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a epub
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Mycoplasma genitalium
|2 Other
650 _ 7 |a Antibody
|2 Other
650 _ 7 |a Genital
|2 Other
650 _ 7 |a HPV
|2 Other
650 _ 7 |a Men
|2 Other
650 _ 7 |a Oral
|2 Other
650 _ 7 |a PID
|2 Other
650 _ 7 |a Serology
|2 Other
650 _ 7 |a Seropersistence
|2 Other
650 _ 7 |a Women
|2 Other
700 1 _ |a Butt, Julia
|0 P:(DE-He78)31d7c3e829be03400641f80b821ef728
|b 1
|u dkfz
700 1 _ |a Michels, Birgitta E
|0 P:(DE-He78)b48bfd64120195b64b5f11d32ce5ed5e
|b 2
|u dkfz
700 1 _ |a Syrjänen, Kari
|b 3
700 1 _ |a Grenman, Seija
|b 4
700 1 _ |a Waterboer, Tim
|0 P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30
|b 5
|u dkfz
700 1 _ |a Syrjänen, Stina
|b 6
700 1 _ |a Louvanto, Karolina
|b 7
773 _ _ |a 10.1186/s12879-025-12334-y
|0 PERI:(DE-600)2041550-3
|p nn
|t BMC infectious diseases
|v nn
|y 2025
|x 1471-2334
909 C O |o oai:inrepo02.dkfz.de:307449
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)31d7c3e829be03400641f80b821ef728
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)b48bfd64120195b64b5f11d32ce5ed5e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2025
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BMC INFECT DIS : 2022
|d 2024-12-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-04-10T15:34:11Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-04-10T15:34:11Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Open peer review
|d 2024-04-10T15:34:11Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-05
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-05
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-05
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2024-12-05
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2024-12-05
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2024-12-05
920 1 _ |0 I:(DE-He78)C230-20160331
|k C230
|l Infektionen und Krebsepidemiologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C230-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21